Header Logo

ADAM COHEN

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address1102 BATES
ORCID ORCID Icon0000-0003-4453-3792 Additional info
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Education, Innovation & Technology
    DivisionDepartment of Education, Innovation


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Weinberger K, Rocha MEM, Keough C, Kumar S, Quinonez R, Su E, Cohen A. Point-of-Care Ultrasound in Pediatric Hospital Medicine: A National Survey. Hosp Pediatr. 2025 Aug 01; 15(8):686-692. PMID: 40633926.
      Citations: 1     Fields:    Translation:Humans
    2. Chen KY, Ross JS, Cohen AB, Karlawish J, Oh ES, Gupta R. Demographic Data Supporting FDA Authorization of AI Devices for Alzheimer Disease and Related Dementias. JAMA. 2025 Jul 30. PMID: 40736371; PMCID: PMC12311817.
      Citations:    Fields:    
    3. Jagannath S, Martin TG, Lin Y, Cohen AD, Raje N, Htut M, Deol A, Agha M, Berdeja JG, Lesokhin AM, Liegel JJ, Rossi A, Lieberman-Cribbin A, Usmani SZ, Dhakal B, Parekh S, Li H, Wang F, Montes de Oca R, Plaks V, Sun H, Banerjee A, Schecter JM, Lendvai N, Madduri D, Lengil T, Zhu J, Koneru M, Akram M, Patel N, Costa Filho O, Jakubowiak AJ, Voorhees PM. Long-Term (=5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma. J Clin Oncol. 2025 Sep; 43(25):2766-2771. PMID: 40459151; PMCID: PMC12393059.
      Citations: 2     Fields:    Translation:Humans
    4. Dalangin R, Jia BZ, Qi Y, Aggarwal A, Sakoi K, Drobizhev M, Molina RS, Patel R, Abdelfattah AS, Zheng J, Reep D, Hasseman JP, GENIE Project Team, Zhao Y, Wu J, Podgorski K, Tebo AG, Schreiter ER, Hughes TE, Terai T, Paquet ME, Megason SG, Cohen AE, Shen Y, Campbell RE. Far-red fluorescent genetically encoded calcium ion indicators. Nat Commun. 2025 Apr 07; 16(1):3318. PMID: 40195305; PMCID: PMC11977202.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    5. Ho M, Paruzzo L, Minehart J, Voruganti T, Devi P, Vogl DT, Cohen AD, Garfall AL, Waxman AJ, Kapur S, Stadtmauer EA, Adaniya SS, Longworth S. Non-tuberculous mycobacterial infections following teclistamab in multiple myeloma. Haematologica. 2025 Jun 01; 110(6):1436-1442. PMID: 39911104; PMCID: PMC12130765.
      Citations:    Fields:    
    6. Costa LJ, Banerjee R, Mian H, Weisel K, Bal S, Derman BA, Htut MM, Nagarajan C, Rodriguez C, Richter J, Frigault MJ, Ye JC, van de Donk NWCJ, Voorhees PM, Puliafito B, Bahlis N, Popat R, Chng WJ, Ho PJ, Kaur G, Kapoor P, Du J, Schjesvold F, Berdeja J, Einsele H, Cohen AD, Mikhael J, Biru Y, Rajkumar SV, Lin Y, Martin TG, Chari A. International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma. Leukemia. 2025 Mar; 39(3):543-554. PMID: 39870767; PMCID: PMC11879857.
      Citations: 12     Fields:    Translation:Humans
    7. Jadlowsky JK, Hexner EO, Marshall A, Grupp SA, Frey NV, Riley JL, Veloso E, McConville H, Rogal W, Czuczman C, Hwang WT, Li Y, Leskowitz RM, Farrelly O, Karar J, Christensen S, Barber-Rotenberg J, Gaymon A, Aronson N, Bernstein W, Melenhorst JJ, Roche AM, Everett JK, Zolnoski SA, McFarland AG, Reddy S, Petrichenko A, Cook EJ, Lee C, Gonzalez VE, Alexander K, Kulikovskaya I, Ram?rez-Fern?ndez ?, Minehart JC, Ruella M, Gill SI, Schuster SJ, Cohen AD, Garfall AL, Shah PD, Porter DL, Maude SL, Levine BL, Siegel DL, Chew A, McKenna S, Lledo L, Davis MM, Plesa G, Herbst F, Stadtmauer EA, Tebas P, DiNofia A, Haas A, Haas NB, Myers R, O'Rourke DM, Svoboda J, Tanyi JL, Aplenc R, Jacobson JM, Ko AH, Cohen RB, June CH, Bushman FD, Fraietta JA. Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies. Nat Med. 2025 Apr; 31(4):1134-1144. PMID: 39833408.
      Citations: 17     Fields:    Translation:HumansCells
    8. Clary C, Cohen A, Kumar S, Sur M, Rissmiller B, Singhal G, Thammasitboon S. The effect of a provisional diagnosis on intern diagnostic reasoning: a mixed methods study. Diagnosis (Berl). 2025 May 01; 12(2):208-216. PMID: 39743792.
      Citations:    Fields:    Translation:Humans
    9. Duque M, Chen AB, Hsu E, Narayan S, Rymbek A, Begum S, Saher G, Cohen AE, Olson DE, Li Y, Prober DA, Bergles DE, Fishman MC, Engert F, Ahrens MB. Ketamine induces plasticity in a norepinephrine-astroglial circuit to promote behavioral perseverance. Neuron. 2025 Feb 05; 113(3):426-443.e5. PMID: 39694033; PMCID: PMC11889991.
      Citations: 6     Fields:    Translation:AnimalsCells
    10. Rodriguez-Otero P, Usmani S, Cohen AD, van de Donk NWCJ, Leleu X, G?llego P?rez-Larraya J, Manier S, Nooka AK, Mateos MV, Einsele H, Minnema M, Cavo M, Derman BA, Puig N, Gay F, Ho PJ, Chng WJ, Kastritis E, Gahrton G, Weisel K, Nagarajan C, Schjesvold F, Mikhael J, Costa L, Raje NS, Zamagni E, H?jek R, Weinhold N, Yong K, Ye JC, Sidhana S, Merlini G, Martin T, Lin Y, Chari A, Popat R, Kaufman JL, International Myeloma Working Group. International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma. Lancet Oncol. 2024 05; 25(5):e205-e216. PMID: 38697166.
      Citations:    
    11. Raje NS, Cohen AD, Patel KK, van de Donk NWCJ, Richter J, San-Miguel J. Practical Aspects of Immunotherapy: A Report from the 20th International Myeloma Society (IMS) Annual Meeting. Clin Lymphoma Myeloma Leuk. 2024 Jun; 24(6):350-357. PMID: 38627181.
      Citations:    
    12. Henry WS, M?ller S, Yang JS, Innes-Gold S, Das S, Reinhardt F, Sigmund K, Phadnis VV, Wan Z, Eaton E, Sampaio JL, Bell GW, Viravalli A, Hammond PT, Kamm RD, Cohen AE, Boehnke N, Hsu VW, Levental KR, Rodriguez R, Weinberg RA. Ether lipids influence cancer cell fate by modulating iron uptake. bioRxiv. 2024 Mar 21. PMID: 38562716; PMCID: PMC10983928.
      Citations:    
    13. Elster MJ, Cohen A, Herchline D, Chieco D, Hoefert J, Denniston S. The transition to Pediatric Hospital Medicine fellowship: A national survey-based needs assessment. J Hosp Med. 2024 03; 19(3):159-164. PMID: 38263765.
      Citations:    Fields:    Translation:Humans
    14. Hasanali ZS, Razzo B, Susanibar-Adaniya SP, Garfall AL, Stadtmauer EA, Cohen AD. Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma. Hematol Oncol Clin North Am. 2024 04; 38(2):383-406. PMID: 38158242; PMCID: PMC11000527.
      Citations:    
    15. . Patient Safety: A Case-based Innovative Playbook for Safer Care. Diagnostic Error. 2023; 215-228. View Publication.
    16. Gertz MA, Cohen AD, Comenzo RL, Kastritis E, Landau HJ, Libby EN, Liedtke M, Sanchorawala V, Sch?nland S, Wechalekar A, Zonder JA, Palladini G, Walling J, Guthrie S, Nie C, Karp C, Jin Y, Kinney GG, Merlini G. Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial. Blood. 2023 10 05; 142(14):1208-1218. PMID: 37366170; PMCID: PMC10644097.
      Citations:    
    17. Eom M, Han S, Park P, Kim G, Cho ES, Sim J, Lee KH, Kim S, Tian H, B?hm UL, Lowet E, Tseng HA, Choi J, Lucia SE, Ryu SH, R?zsa M, Chang S, Kim P, Han X, Piatkevich KD, Choi M, Kim CH, Cohen AE, Chang JB, Yoon YG. Statistically unbiased prediction enables accurate denoising of voltage imaging data. Nat Methods. 2023 Oct; 20(10):1581-1592. PMID: 37723246; PMCID: PMC10555843.
      Citations:    
    18. Htut M, Dhakal B, Cohen AD, Martin T, Berdeja JG, Usmani SZ, Agha M, Jackson CC, Madduri D, Deraedt W, Zudaire E, Yeh TM, Xu X, Pacaud L, Akram M, Jagannath S. Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 Study. Clin Lymphoma Myeloma Leuk. 2023 12; 23(12):882-888. PMID: 37716872.
      Citations:    
    19. Cohen A. Rounding in the Time of COVID. J Grad Med Educ. 2023 08; 15(4):447-448. PMID: 37637340; PMCID: PMC10449357.
      Citations:    
    20. Jagannath S, Joseph N, Crivera C, Kharat A, Jackson CC, Valluri S, Cost P, Phelps H, Slowik R, Klein T, Smolen L, Yu X, Cohen AD. Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients?with Multiple Myeloma. Oncol Ther. 2023 Jun; 11(2):263-275. PMID: 37014590; PMCID: PMC10260711.
      Citations:    
    21. Mittal MK, Tieder JS, Westphal K, Sullivan E, Hall M, Bochner R, Cohen A, Colgan JY, Delaney AC, DeLaroche AM, Graf T, Harper B, Kaplan RL, Neubauer HC, Neuman MI, Shastri N, Wilkins V, Stephans A. Diagnostic testing for evaluation of brief resolved unexplained events. Acad Emerg Med. 2023 06; 30(6):662-670. PMID: 36653969.
      Citations:    Fields:    Translation:Humans
    22. Doswell A, Anderst J, Tieder JS, Herman BE, Hall M, Wilkins V, Knochel ML, Kaplan R, Cohen A, DeLaroche AM, Harper B, Mittal MK, Shastri N, Prusakowski M, Puls HT, Brief Resolved Unexplained Event Research and Quality Improvement Network. Diagnostic testing for and detection of physical abuse in infants with brief resolved unexplained events. Child Abuse Negl. 2023 01; 135:105952. PMID: 36423537.
      Citations:    Fields:    Translation:Humans
    23. Cohen AD, Hari P, Htut M, Berdeja JG, Usmani SZ, Madduri D, Olyslager Y, Goldberg JD, Schecter JM, Jackson CC, Gries KS, Fastenau JM, Valluri S, Deraedt W, Akram M, Crawford R, Morrison R, Doward L, Morgan K, Seldam ST, Jakubowiak A, Jagannath S. Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study. Clin Lymphoma Myeloma Leuk. 2023 01; 23(1):68-77. PMID: 36357295.
      Citations:    
    24. Martin T, Lin Y, Agha M, Cohen AD, Htut M, Stewart AK, Hari P, Berdeja JG, Usmani SZ, Yeh TM, Olyslager Y, Goldberg JD, Schecter JM, Madduri D, Jackson CC, Deraedt W, Gries KS, Fastenau JM, Trudeau JJ, Akram M, Pacaud L, Jakubowiak A, Jagannath S. Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b-2, open-label study. Lancet Haematol. 2022 Dec; 9(12):e897-e905. PMID: 36215989.
      Citations:    
    25. Kirkman K, Prudowsky ZD, Shah S, Demmler Harrison G, Rao S, Cohen A. A 14-Year-Old Female With Chest Mass, Shortness of Breath, and Hypertension. Pediatrics. 2022 10 01; 150(4). PMID: 36073194.
      Citations:    
    26. Cohen A, Sur M, Falco C, Dhaliwal G, Singhal G, Thammasitboon S. Using the Assessment of Reasoning Tool to facilitate feedback about diagnostic reasoning. Diagnosis (Berl). 2022 11 01; 9(4):476-484. PMID: 36073963.
      Citations:    
    27. Martin T, Usmani SZ, Berdeja JG, Agha M, Cohen AD, Hari P, Avigan D, Deol A, Htut M, Lesokhin A, Munshi NC, O'Donnell E, Stewart AK, Schecter JM, Goldberg JD, Jackson CC, Yeh TM, Banerjee A, Allred A, Zudaire E, Deraedt W, Olyslager Y, Zhou C, Pacaud L, Madduri D, Jakubowiak A, Lin Y, Jagannath S. Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up. J Clin Oncol. 2023 02 20; 41(6):1265-1274. PMID: 35658469; PMCID: PMC9937098.
      Citations:    
    28. Cohen AB, Stump L, Krumholz HM, Cartiera M, Jain S, Scott Sussman L, Hsiao A, Lindop W, Ying AK, Kaul RL, Balcezak TJ, Tereffe W, Comerford M, Jacoby D, Navai N. Aligning mission to digital health strategy in academic medical centers. NPJ Digit Med. 2022 Jun 02; 5(1):67. PMID: 35654885; PMCID: PMC9163186.
      Citations:    
    29. Matiello M, Cohen AB. Telehealth for Comprehensive Care of Acute Neurologic Disorders. Semin Neurol. 2022 02; 42(1):12-17. PMID: 35576927.
      Citations:    
    30. Cohen AD, Parekh S, Santomasso BD, G?llego P?rez-Larraya J, van de Donk NWCJ, Arnulf B, Mateos MV, Lendvai N, Jackson CC, De Braganca KC, Schecter JM, Marquez L, Lee E, Cornax I, Zudaire E, Li C, Olyslager Y, Madduri D, Varsos H, Pacaud L, Akram M, Geng D, Jakubowiak A, Einsele H, Jagannath S. Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies. Blood Cancer J. 2022 02 24; 12(2):32. PMID: 35210399; PMCID: PMC8873238.
      Citations:    
    31. Raje NS, Anaissie E, Kumar SK, Lonial S, Martin T, Gertz MA, Krishnan A, Hari P, Ludwig H, O'Donnell E, Yee A, Kaufman JL, Cohen AD, Garderet L, Wechalekar AF, Terpos E, Khatry N, Niesvizky R, Yi Q, Joshua DE, Saikia T, Leung N, Engelhardt M, Mothy M, Branagan A, Chari A, Reiman AJ, Lipe B, Richter J, Rajkumar SV, Miguel JS, Anderson KC, Stadtmauer EA, Prabhala RH, McCarthy PL, Munshi NC, Garderet L, Mothy M, Miguel JS. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group. Lancet Haematol. 2022 Feb; 9(2):e143-e161. PMID: 35114152.
      Citations: 1     Fields:    Translation:Humans
    32. Sheikh Z, Selioutski O, Taraschenko O, Gilmore EJ, Westover MB, Cohen AB. Systematic Evaluation of Research Priorities in Critical Care Electroencephalography. J Clin Neurophysiol. 2023 Jul 01; 40(5):426-433. PMID: 35066530; PMCID: PMC9296700.
      Citations:    
    33. Cohen A, Montez K, Orr C, Konrath J, Oddiri U, Russell CJ, Gambill L, Nesiama JA, Chung PJ, McNeal-Trice K. Changing Who Has a Seat and Voice at the Table: How the Academic Pediatric Association is Responding to Systemic Racism. Acad Pediatr. 2022 04; 22(3):352-355. PMID: 35032709.
      Citations:    Fields:    Translation:Humans
    34. Cohen AB, Hellstrom WJ, Hodges SJ. Persistent Genital Arousal and Major Depressive Disorder in an Adolescent Male: Case Report and Discussion. Urology. 2021 11; 157:239-241. PMID: 34433014.
      Citations:    
    35. Lonial S, Lee HC, Badros A, Trudel S, Nooka AK, Chari A, Abdallah AO, Callander N, Sborov D, Suvannasankha A, Weisel K, Voorhees PM, Womersley L, Baron J, Piontek T, Lewis E, Opalinska J, Gupta I, Cohen AD. Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study. Cancer. 2021 11 15; 127(22):4198-4212. PMID: 34314018; PMCID: PMC8597112.
      Citations:    
    36. Al Tanoury Z, Zimmerman JF, Rao J, Sieiro D, McNamara HM, Cherrier T, Rodr?guez-delaRosa A, Hick-Colin A, Bousson F, Fugier-Schmucker C, Marchiano F, Habermann B, Chal J, Nesmith AP, Gapon S, Wagner E, Gupta VA, Bassel-Duby R, Olson EN, Cohen AE, Parker KK, Pourqui? O. Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro. Proc Natl Acad Sci U S A. 2021 07 13; 118(28). PMID: 34260377; PMCID: PMC8285911.
      Citations:    
    37. DeLaroche AM, Hall M, Mittal MK, Neuman MI, Stephans A, Wilkins VL, Sullivan E, Cohen A, Kaplan RL, Shastri NL, Tieder JS, BRIEF RESOLVED UNEXPLAINED EVENTS RESEARCH AND QUALITY IMPROVEMENT COLLABORATIVE. Accuracy of Diagnostic Codes for Identifying Brief Resolved Unexplained Events. Hosp Pediatr. 2021 07; 11(7):726-749. PMID: 34183363.
      Citations:    Fields:    Translation:Humans
    38. Tieder JS, Sullivan E, Stephans A, Hall M, DeLaroche AM, Wilkins V, Neuman MI, Mittal MK, Kane E, Jain S, Shastri N, Katsogridakis Y, Vachani JG, Hochreiter D, Kim E, Nicholson J, Bochner R, Murphy K, Brief Resolved Unexplained Event Research and Quality Improvement Network. Risk Factors and Outcomes After a Brief Resolved Unexplained Event: A Multicenter Study. Pediatrics. 2021 07; 148(1). PMID: 34168059.
      Citations: 1     Fields:    Translation:Humans
    39. Berdeja JG, Madduri D, Usmani SZ, Jakubowiak A, Agha M, Cohen AD, Stewart AK, Hari P, Htut M, Lesokhin A, Deol A, Munshi NC, O'Donnell E, Avigan D, Singh I, Zudaire E, Yeh TM, Allred AJ, Olyslager Y, Banerjee A, Jackson CC, Goldberg JD, Schecter JM, Deraedt W, Zhuang SH, Infante J, Geng D, Wu X, Carrasco-Alfonso MJ, Akram M, Hossain F, Rizvi S, Fan F, Lin Y, Martin T, Jagannath S. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study. Lancet. 2021 07 24; 398(10297):314-324. PMID: 34175021.
      Citations:    
    40. Cohen A, Kind T, DeWolfe C. A Qualitative Exploration of the Intern Experience in Assessing Medical Student Performance. Acad Pediatr. 2021 May-Jun; 21(4):728-734. PMID: 33127592.
      Citations:    Fields:    Translation:Humans
    41. Richardson PG, Lee HC, Abdallah AO, Cohen AD, Kapoor P, Voorhees PM, Hoos A, Wang K, Baron J, Piontek T, Byrne J, Richmond S, Jewell RC, Opalinska J, Gupta I, Lonial S. Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study. Blood Cancer J. 2020 10 23; 10(10):106. PMID: 33097687; PMCID: PMC7584571.
      Citations:    
    42. Kumar SK, Jacobus SJ, Cohen AD, Weiss M, Callander N, Singh AK, Parker TL, Menter A, Yang X, Parsons B, Kumar P, Kapoor P, Rosenberg A, Zonder JA, Faber E, Lonial S, Anderson KC, Richardson PG, Orlowski RZ, Wagner LI, Rajkumar SV. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Oncol. 2020 10; 21(10):1317-1330. PMID: 32866432; PMCID: PMC7591827.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    43. Cohen A, Sur M, Weisse M, Moffett K, Lancaster J, Saggio R, Singhal G, Thammasitboon S. Teaching Diagnostic Reasoning to Faculty Using an Assessment for Learning Tool: Training the Trainer. MedEdPORTAL. 2020 08 21; 16:10938. PMID: 32875089; PMCID: PMC7449581.
      Citations:    Fields:    Translation:Humans
    44. Holstein SA, Howard A, Avigan D, Bhutani M, Cohen AD, Costa LJ, Dhodapkar MV, Gay F, Gormley N, Green DJ, Hillengass J, Korde N, Li Z, Mailankody S, Neri P, Parekh S, Pasquini MC, Puig N, Roodman GD, Samur MK, Shah N, Shah UA, Shi Q, Spencer A, Suman VJ, Usmani SZ, McCarthy PL. Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling. Biol Blood Marrow Transplant. 2020 10; 26(10):e247-e255. PMID: 32589921; PMCID: PMC7529908.
      Citations:    
    45. Cohen AB, Dorsey ER, Mathews SC, Bates DW, Safavi K. A digital health industry cohort across the health continuum. NPJ Digit Med. 2020; 3:68. PMID: 32411829; PMCID: PMC7217869.
      Citations:    
    46. Ailawadhi S, Sexton R, Lentzsch S, Abidi MH, Voorhees PM, Cohen AD, Rohren EM, Heitner S, Kelly K, Mackler NJ, Baer DM, Hoering A, Durie B, Orlowski RZ. Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma. Clin Cancer Res. 2020 08 01; 26(15):3969-3978. PMID: 32299820; PMCID: PMC7415520.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    47. Cohen AB, Mathews SC, Dorsey ER, Bates DW, Safavi K. Direct-to-consumer digital health. Lancet Digit Health. 2020 04; 2(4):e163-e165. PMID: 33328077.
      Citations:    
    48. Cohen A, Morrow A, McClure M. Full-Body Rash and Fever in a 15-Year-Old Male. Clin Pediatr (Phila). 2020 09; 59(9-10):933-937. PMID: 31994411.
      Citations:    Fields:    Translation:Humans
    49. Fajgenbaum DC, Langan RA, Japp AS, Partridge HL, Pierson SK, Singh A, Arenas DJ, Ruth JR, Nabel CS, Stone K, Okumura M, Schwarer A, Jose FF, Hamerschlak N, Wertheim GB, Jordan MB, Cohen AD, Krymskaya V, Rubenstein A, Betts MR, Kambayashi T, van Rhee F, Uldrick TS. Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease. J Clin Invest. 2019 08 13; 129(10):4451-4463. PMID: 31408438; PMCID: PMC6763254.
      Citations:    
    50. Trudel S, Lendvai N, Popat R, Voorhees PM, Reeves B, Libby EN, Richardson PG, Hoos A, Gupta I, Bragulat V, He Z, Opalinska JB, Cohen AD. Antibody-drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study. Blood Cancer J. 2019 03 20; 9(4):37. PMID: 30894515; PMCID: PMC6426965.
      Citations:    
    51. Cohen AD, Lendvai N, Nataraj S, Imai N, Jungbluth AA, Tsakos I, Rahman A, Mei AH, Singh H, Zarychta K, Kim-Schulze S, Park A, Venhaus R, Alpaugh K, Gnjatic S, Cho HJ. Autologous Lymphocyte Infusion Supports Tumor Antigen Vaccine-Induced Immunity in Autologous Stem Cell Transplant for Multiple Myeloma. Cancer Immunol Res. 2019 04; 7(4):658-669. PMID: 30745365.
      Citations:    
    52. Safavi K, Mathews SC, Bates DW, Dorsey ER, Cohen AB. Top-Funded Digital Health Companies And Their Impact On High-Burden, High-Cost Conditions. Health Aff (Millwood). 2019 01; 38(1):115-123. PMID: 30615535.
      Citations: 25     Fields:    Translation:Humans
    53. Shah SJ, Schwamm LH, Cohen AB, Simoni MR, Estrada J, Matiello M, Venkataramani A, Rao SK. Virtual Visits Partially Replaced In-Person Visits In An ACO-Based Medical Specialty Practice. Health Aff (Millwood). 2018 12; 37(12):2045-2051. PMID: 30633681.
      Citations:    
    54. Trudel S, Lendvai N, Popat R, Voorhees PM, Reeves B, Libby EN, Richardson PG, Anderson LD, Sutherland HJ, Yong K, Hoos A, Gorczyca MM, Lahiri S, He Z, Austin DJ, Opalinska JB, Cohen AD. Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial. Lancet Oncol. 2018 12; 19(12):1641-1653. PMID: 30442502; PMCID: PMC6328058.
      Citations:    
    55. Shah JJ, Kaufman JL, Zonder JA, Cohen AD, Bensinger WI, Hilder BW, Rush SA, Walker DH, Tunquist BJ, Litwiler KS, Ptaszynski M, Orlowski RZ, Lonial S. A Phase 1 and 2 study of Filanesib alone and in combination with low-dose dexamethasone in relapsed/refractory multiple myeloma. Cancer. 2017 Dec 01; 123(23):4617-4630. PMID: 28817190; PMCID: PMC5856158.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    56. Sanchorawala V, Palladini G, Kukreti V, Zonder JA, Cohen AD, Seldin DC, Dispenzieri A, Jaccard A, Schönland SO, Berg D, Yang H, Gupta N, Hui AM, Comenzo RL, Merlini G, Sch?nland SO. A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis. Blood. 2017 08 03; 130(5):597-605. PMID: 28550039; PMCID: PMC6911836.
      Citations:    
    57. Raje NS, Faber EA, Richardson PG, Schiller G, Hohl RJ, Cohen AD, Forero A, Carpenter S, Nguyen TS, Conti I, Kaiser CJ, Cronier DM, Wooldridge JE, Anderson KC. Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma. Clin Cancer Res. 2016 Dec 01; 22(23):5688-5695. PMID: 27287072.
      Citations:    
    58. Henderson MJ, Baldwin HA, Werley CA, Boccardo S, Whitaker LR, Yan X, Holt GT, Schreiter ER, Looger LL, Cohen AE, Kim DS, Harvey BK. A Low Affinity GCaMP3 Variant (GCaMPer) for Imaging the Endoplasmic Reticulum Calcium Store. PLoS One. 2015; 10(10):e0139273. PMID: 26451944; PMCID: PMC4599735.
      Citations:    
    59. Shah JJ, Stadtmauer EA, Abonour R, Cohen AD, Bensinger WI, Gasparetto C, Kaufman JL, Lentzsch S, Vogl DT, Gomes CL, Pascucci N, Smith DD, Orlowski RZ, Durie BG. Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma. Blood. 2015 Nov 12; 126(20):2284-90. PMID: 26384354; PMCID: PMC4643003.
      Citations: 68     Fields:    Translation:HumansCTClinical Trials
    60. Benson DM, Cohen AD, Jagannath S, Munshi NC, Spitzer G, Hofmeister CC, Efebera YA, Andre P, Zerbib R, Caligiuri MA. A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma. Clin Cancer Res. 2015 Sep 15; 21(18):4055-61. PMID: 25999435; PMCID: PMC4573800.
      Citations:    
    61. Cheng EM, Sanders AE, Cohen AB, Bever CT. Quality measurement: It's here to stay. Neurol Clin Pract. 2014 Oct; 4(5):441-446. PMID: 25317378; PMCID: PMC4196461.
      Citations:    
    62. Zou P, Zhao Y, Douglass AD, Hochbaum DR, Brinks D, Werley CA, Harrison DJ, Campbell RE, Cohen AE. Bright and fast multicoloured voltage reporters via electrochromic FRET. Nat Commun. 2014 Aug 13; 5:4625. PMID: 25118186; PMCID: PMC4134104.
      Citations:    
    63. Raje N, Faiman B, Harvey RD, Kurtin SE, Lonial S, Kumar SK, Cohen AD, Conde MA, Giralt SA, Recine MS, Tombler ER, Stadtmauer E, Jagannath S, Anderson KC, Managing Myeloma Continuing Education Initiative Advisory Group. Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee. Clin Lymphoma Myeloma Leuk. 2014 Oct; 14(5):356-69. PMID: 25066040.
      Citations:    
    64. Langer-Gould AM, Anderson WE, Armstrong MJ, Cohen AB, Eccher MA, Iverson DJ, Potrebic SB, Becker A, Larson R, Gedan A, Getchius TS, Gronseth GS. The American Academy of Neurology's top five choosing wisely recommendations. Neurology. 2013 Sep 10; 81(11):1004-11. PMID: 23430685.
      Citations:    
    65. Cohen AB, Sanders AE, Swain-Eng RJ, Gjorvad G, Tonn ST, Bever CT, Cheng EM. Quality measures for neurologists: Financial and practice implications. Neurol Clin Pract. 2013 Feb; 3(1):44-51. PMID: 23634383; PMCID: PMC3613219.
      Citations:    
    COHEN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (240)
    Explore
    _
    Co-Authors (16)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _